Petrie M, Borlaug B, Buchholtz K et al (2024) HERMES: effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation
Unintentional weight loss : Beyond expected therapeutic weight reduction, or inability to maintain adequate nutrition
In this regard, it is noteworthy that metformin increases intestinal glucose utilisation [3], which perhaps could be coupled to GLP-1 production
[PMID: 10460796] PubMed record related to this compound for laboratory literature review
This was a randomized, head-to-head comparison that enrolled 751 individuals and found those who took tirzepatide lost 20% of their body weight, about 50 pounds on average, while those on semaglutide lost 14% of their body weight, or about 33 pounds on average